144 related articles for article (PubMed ID: 7773939)
1. c-erbB-2 and p53 expression in fallopian tube carcinoma.
Lacy MQ; Hartmann LC; Keeney GL; Cha SC; Wieand HS; Podratz KC; Roche PC
Cancer; 1995 Jun; 75(12):2891-6. PubMed ID: 7773939
[TBL] [Abstract][Full Text] [Related]
2. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
3. Primary endometrioid carcinoma of fallopian tube. Clinicomorphologic study.
Rabczyński J; Ziółkowski P
Pathol Oncol Res; 1999; 5(1):61-6. PubMed ID: 10079381
[TBL] [Abstract][Full Text] [Related]
4. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
5. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
6. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
[TBL] [Abstract][Full Text] [Related]
7. Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.
van der Zee AG; Hollema H; Suurmeijer AJ; Krans M; Sluiter WJ; Willemse PH; Aalders JG; de Vries EG
J Clin Oncol; 1995 Jan; 13(1):70-8. PubMed ID: 7799045
[TBL] [Abstract][Full Text] [Related]
8. HER-2/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study.
Nowee ME; Dorsman JC; Piek JM; Kosma VM; Hämäläinen K; Verheijen RH; van Diest PJ
Histopathology; 2007 Nov; 51(5):666-73. PubMed ID: 17927588
[TBL] [Abstract][Full Text] [Related]
9. BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?
Cass I; Holschneider C; Datta N; Barbuto D; Walts AE; Karlan BY
Obstet Gynecol; 2005 Dec; 106(6):1327-34. PubMed ID: 16319259
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
11. p53 expression in fallopian tube carcinomas.
Rosen AC; Ausch C; Klein M; Graf AH; Metzenbauer M; Philipp K; Reiner A
Cancer Lett; 2000 Aug; 156(1):1-7. PubMed ID: 10840153
[TBL] [Abstract][Full Text] [Related]
12. Unexpected primary fallopian tube carcinoma during gynecological operations: Clinicopathological and prognostic factors analyses of 67 cases.
Sun M; Bao L; Shen H; Ji M; Yao L; Yi X; Jiang W
Taiwan J Obstet Gynecol; 2019 Sep; 58(5):626-632. PubMed ID: 31542083
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of p53 and HER-2/neu and c-myc in primary fallopian tube carcinoma.
Chung TK; Cheung TH; To KF; Wong YF
Gynecol Obstet Invest; 2000; 49(1):47-51. PubMed ID: 10629373
[TBL] [Abstract][Full Text] [Related]
14. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival.
Reinartz JJ; George E; Lindgren BR; Niehans GA
Hum Pathol; 1994 Oct; 25(10):1075-83. PubMed ID: 7927313
[TBL] [Abstract][Full Text] [Related]
15. Primary cancer of the fallopian tube with transitional differentiation. Clinical and pathological assessment of 6 cases.
Rabczyński JK; Kochman AT
Neoplasma; 1999; 46(2):128-31. PubMed ID: 10466438
[TBL] [Abstract][Full Text] [Related]
16. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
[TBL] [Abstract][Full Text] [Related]
17. Early occurrence and prognostic significance of p53 alteration in primary carcinoma of the fallopian tube.
Zheng W; Sung CJ; Cao P; Zhang ZF; Cai R; Godwin TA; Kramer EE; Lauchlan SC
Gynecol Oncol; 1997 Jan; 64(1):38-48. PubMed ID: 8995545
[TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
[TBL] [Abstract][Full Text] [Related]
19. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
Pich A; Margaria E; Chiusa L
J Clin Oncol; 2000 Aug; 18(16):2948-56. PubMed ID: 10944127
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of c-erbB-2 and p53 protein expressions in gastric carcinoma--a multivariate analysis of prognostic factors.
Kim JP; Oh ST; Hwang TS; Chi JG
J Korean Med Sci; 1994 Jun; 9(3):248-53. PubMed ID: 7993593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
